Emmanuelle Coutanceau - Profile and Investment Details

Investor Profile

Emmanuelle Coutanceau is a Venture Capital, Private Equity Firm, Angel/Individual based in Copenhagen, Capital Region of Denmark, Denmark with a diverse investment portfolio that includes companies such as IO Biotech, Pherecydes Pharma, Draupnir Bio, HepaRegeniX GmbH, Corwave, Theranexus, Antag Therapeutics, Inthera, . Over time, Emmanuelle Coutanceau has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Emmanuelle Coutanceau is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Equities, Investment Management, Infrastructure, Energy, Healthcare Innovation, Life Science, Portfolio Management, Nordic Countries-based Startups, Medical Technologies, Finance, Biotechnology, Medical Devices, Innovation, FinTech, Utilities, Social Impact, Renewable Energy, Medical, B2B, Real Estate, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Emmanuelle Coutanceau, as their portfolio suggests a familiarity and interest in this area.

Understanding Emmanuelle Coutanceau’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.